Epigenetics of cervical cancer. An overview and therapeutic perspectives - Wikidata - awgldk - TriplyDB

Epigenetics of cervical cancer. An overview and therapeutic perspectives

Epigenetics of cervical cancer. An overview and therapeutic perspectives

http://www.wikidata.org/entity/Q24812104

about

Overexpression of Cancer-Associated Genes via Epigenetic Derepression Mechanisms in Gynecologic Cancer Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acid The overexpression of MCPH1 inhibits cell growth through regulating cell cycle-related proteins and activating cytochrome c-caspase 3 signaling in cervical cancer Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines.Aberrant DNA methylation in cervical carcinogenesis Human papillomavirus induced transformation in cervical and head and neck cancers Molecular mechanisms of HPV mediated neoplastic progression NFBD1/MDC1 is a protein of oncogenic potential in human cervical cancer Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly.The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase.Overexpression of ezrin and galectin-3 as predictors of poor prognosis of cervical cancer.DNA promoter methylation-dependent transcription of the double C2-like domain β (DOC2B) gene regulates tumor growth in human cervical cancer The anti-aging gene KLOTHO is a novel target for epigenetic silencing in human cervical carcinoma Nuclear localizaiton of β-catenin is associated with poor survival and chemo-/radioresistance in human cervical squamous cell cancer.A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results.Epigenetic linkage of aging, cancer and nutrition.DNA methylation profiling across the spectrum of HPV-associated anal squamous neoplasia.Associations between methylation of paternally expressed gene 3 (PEG3), cervical intraepithelial neoplasia and invasive cervical cancer.Radiosensitizers in cervical cancer. Cisplatin and beyond.New molecular targets against cervical cancer.Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer.Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer.Methylated Host Cell Gene Promoters and Human Papillomavirus Type 16 and 18 Predicting Cervical Lesions and Cancer.Association between human papillomavirus and Epstein - Barr virus DNA and gene promoter methylation of RB1 and CDH1 in the cervical lesions: a transversal study The effects of DNA methylation and histone deacetylase inhibitors on human papillomavirus early gene expression in cervical cancer, an in vitro and clinical study Notch1-mediated tumor suppression in cervical cancer with the involvement of SST signaling and its application in enhanced SSTR-targeted therapeutics.Patterns of cellular and HPV 16 methylation as biomarkers for cervical neoplasia.DNA methylation profile at the DNMT3L promoter: a potential biomarker for cervical cancer.Longitudinal assessment of DNA methylation changes during HPVE6E7-induced immortalization of primary keratinocytes.Recent advances in the search for antiviral agents against human papillomaviruses.Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer.Epigenetic alterations in preneoplastic and neoplastic lesions of the cervix Sequential gene promoter methylation during HPV-induced cervical carcinogenesis Gene discovery in cervical cancer : towards diagnostic and therapeutic biomarkers.Human wings apart-like gene is specifically overexpressed in cervical cancer.Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests Notch Signaling Activation in Cervical Cancer Cells Induces Cell Growth Arrest with the Involvement of the Nuclear Receptor NR4A2.Trichostatin A Enhances the Apoptotic Potential of Palladium Nanoparticles in Human Cervical Cancer Cells.Epigenetics of oropharyngeal squamous cell carcinoma: opportunities for novel chemotherapeutic targets.Histone H3 Acetyl K9 and Histone H3 Tri Methyl K4 as Prognostic Markers for Patients with Cervical Cancer.

P2860

Q21129296-9C302883-B3C8-4DE7-B398-63D468C8FA6A Q24288944-FE45DB88-68AB-48E8-A14D-C249374DDFCB Q24339317-1E998A4B-7C88-4F39-A374-E3E32A720120 Q25255934-9D02BD16-ADFC-43A6-88B2-523D3AAB7C95 Q26830289-177D8119-4156-4030-95DC-CFA48CBD8B57 Q27003141-729276ED-FD6A-4C87-983F-1B104577F6D8 Q28070323-6111CF96-0D7B-4D30-8EC8-4F698E34A4C6 Q28245966-6DE0EA86-715F-41AB-821D-A6966351965C Q30431647-72BDE758-CCC9-48EA-86DF-A6B6D202E5FF Q33627886-EC1B8803-4363-4FE7-BDBD-9565AB034A0C Q33653371-D293FE93-0038-4276-A980-611DE9CCACA5 Q33675798-A125B652-CCB6-4DAB-85C8-FEE41880FF10 Q33911922-93D79E41-2BF9-47BD-B90A-FF6F1ABCDFAA Q34029022-E456338E-157B-40AA-AD75-FA68C441AEC9 Q34142430-F5369C64-1A30-4FA8-9FBC-67F5770E3247 Q34457187-3CC47783-CCB1-40F3-B423-10AD6D730428 Q34505483-BC70CF22-D2ED-4F47-B701-20753CDB0D00 Q34589981-7BB08F9C-77D6-493E-941E-C0488D7037B8 Q34684307-083C678C-14CA-493C-8D46-56981E88EA8A Q34700859-0378E967-D287-426D-B4F6-B889EE68A44C Q35082777-85EADBC9-443F-42B4-A5AE-057FE1F171FD Q35613632-D81FAF07-EB88-450C-8D75-44DA0FEBD4E7 Q35658044-3C583FA5-07DB-4A38-9507-281658F619A3 Q35670508-7B0BEE71-DE8C-4D17-94A8-54E35677F1C7 Q35674823-DA015978-9D24-4025-A694-C5008AE093E7 Q35776244-46703111-AA53-45A3-9CD4-9A563B27BB8F Q36095106-4D9EB32A-D5EE-4CD8-A217-B8BF201B5CC8 Q36148943-ABC1E68C-22E2-4CA6-B434-6DB2F7D700DE Q36212820-201E9FCE-14ED-40BB-B760-E20982552486 Q36284493-950B3815-3E9B-4B3E-A940-4325DC0AD458 Q36340870-951C87B3-5026-4EAC-BD85-9FBDBF0F76C2 Q36412445-FEF3A9FC-3503-4800-9162-6F204BF929D8 Q36610652-25B78445-1915-4EBE-A32F-17FD6FFE75E8 Q36982644-8D256FB0-26BD-4F7C-B1C9-8BD6443A9770 Q37002633-A0F0D18B-7E22-4F3A-85B4-AB9BC3C4E799 Q37111527-46C06B1A-F9C9-47D7-AFC3-A8C1E0375EA9 Q37133625-F4BF23D1-D7A0-4ABD-92A4-0AC3C20F481C Q37210234-FCCC0F6B-6725-4DC3-AC9F-B68EAB680C2A Q37615798-719E4236-999F-454B-BFF6-4BC7E14FC4C0 Q37728983-97C62471-01AC-4E6B-B71A-97EE3D5421F5

P2860

Epigenetics of cervical cancer. An overview and therapeutic perspectives

http://www.wikidata.org/entity/Q24812104

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Epigenetics of cervical cancer. An overview and therapeutic perspectives

@ast

Epigenetics of cervical cancer. An overview and therapeutic perspectives

@en

Epigenetics of cervical cancer. An overview and therapeutic perspectives

@nl

type

label

Epigenetics of cervical cancer. An overview and therapeutic perspectives

@ast

Epigenetics of cervical cancer. An overview and therapeutic perspectives

@en

Epigenetics of cervical cancer. An overview and therapeutic perspectives

@nl

prefLabel

Epigenetics of cervical cancer. An overview and therapeutic perspectives

@ast

Epigenetics of cervical cancer. An overview and therapeutic perspectives

@en

Epigenetics of cervical cancer. An overview and therapeutic perspectives

@nl

P1433

Q24812104-663836B6-AA5B-4ADE-AC81-D74D78F1CBCF

P1476

Q24812104-8B66B200-4A68-4B14-9D62-A0949CD9C54D

P2093

Q24812104-3D1739A4-CAE1-43EF-9816-25EA4E9D1B60

Q24812104-4B161EB3-C0D7-48B2-B0A9-56EB451CBC35

Q24812104-747137C3-031A-4EC7-86EB-6495043B4306

Q24812104-7FF20486-985F-4273-8C67-D9070F796A3D

Q24812104-9C307D2C-EBF6-43CE-AC3C-3EB84CB05A73

Q24812104-FC9E9B41-3971-481F-9BAF-3C24D5D42564

P275

Q24812104-6B8D9A10-91FC-4CA1-AB22-4822558F681E

P2860

Q24812104-000EE5C8-5F2E-4B95-933F-5DA71C97C9BA

Q24812104-0044C658-8D5E-446A-BC7F-260CAD3FF81D

Q24812104-00979C88-6931-40B5-BBA7-B67A691AC38B

Q24812104-01CBA416-892F-4B4C-AD54-A9001FCD8376

Q24812104-02CDE320-01F5-4FB9-B2E6-4CFDD697C3CD

Q24812104-02D9C4F3-494D-4462-93FD-CE1783B546A8

Q24812104-03170243-C937-4714-9722-F52453933B59

Q24812104-03F4C8F2-6813-4042-8368-E3D03DC92E40

Q24812104-05B33C21-691E-42E6-BD19-8BFCEC0BBAC1

Q24812104-065E54B6-1DCC-48F7-9D38-6DE49DB70A69

P2888

Q24812104-B1ECFDCC-E1C6-4EEF-B459-4A9058C0AF79

P304

Q24812104-B8E4C0D5-199B-43FB-A8BE-5643D151C7F9

P31

Q24812104-0D361487-E567-47F8-9530-BE4548C4F907

Q24812104-67079EA1-4356-4543-B79A-69CD8FB94672

P3181

Q24812104-EBB2C5BB-4EF5-4AD3-9BA8-CD58C4AFB9B8

P356

Q24812104-626E1A60-089F-4F2A-9C3A-AB8B7E54BB9C

P407

Q24812104-D5FA5420-BFA8-4807-99D0-E84875FD7359

P433

Q24812104-3053F698-2FB4-44C6-8EC0-4455637C8945

P478

Q24812104-3134C871-38FD-412E-8138-3CC11183C821

P5008

Q24812104-71FECD5D-08CA-4C30-9C9E-58892E309AEE

P577

Q24812104-C7861C60-021B-4DFF-8DD0-4EEF6FEE276E

P5875

Q24812104-D3913499-F8E7-445D-81EA-EB533D208AB3

P6179

Q24812104-801893AC-2A5A-42BD-91AF-E1F2F0895E19

P698

Q24812104-B9735C09-91D6-43F9-A753-781040D5CD8D

P921

Q24812104-05A134FB-F40E-4A69-AC79-E3B90141B586

Q24812104-377C0BEB-13CD-4B8B-AE3D-AD997B16929D

Q24812104-DC27A8C2-B910-4338-90F2-EB37AAAF97B3

P932

Q24812104-1D8F33A0-8591-4DE9-B173-C52577A24F46

P3181

P356

P1433

Molecular Cancer

P1476

Epigenetics of cervical cancer. An overview and therapeutic perspectives

@en

P2093

Alfonso Dueñas-González

http://www.w3.org/2001/XMLSchema#string

Claudia Arce

http://www.w3.org/2001/XMLSchema#string

Eduardo Cervera

http://www.w3.org/2001/XMLSchema#string

Lucely Cetina

http://www.w3.org/2001/XMLSchema#string

Marcela Lizano

http://www.w3.org/2001/XMLSchema#string

Myrna Candelaria

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development

The Changing Concept of Epigenetics

DNA methylation patterns and epigenetic memory

Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death

Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT

DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts

The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome

Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome

A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes

P2888

P304

38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3980393

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1476-4598-4-38

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2005-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7517541

http://www.w3.org/2001/XMLSchema#string

P6179

1024870627

http://www.w3.org/2001/XMLSchema#string

P698

16248899

http://www.w3.org/2001/XMLSchema#string

P921

cervical cancer

regulation of gene expression

uterine cervix neoplasm

P932

1291396

http://www.w3.org/2001/XMLSchema#string